It's been a promising month or so for Wall Street following the news from Moderna Inc MRNA and the Pfizer Inc PFE—BioNTech BNTX pair estimating that their COVID-19 vaccine candidates had been more than 90% effective during Phase 3 stage testing.
The S&P 500, Dow Jones, and Russell 2000 have all made new all-time highs in the weeks since, as investors have gotten more hopeful that the worst of the pandemic is behind us. This rising sentiment has come despite many analysts predicting that the S&P 500 could trade lower in the long term during a Joe Biden presidency.
Travis McGhee, chief commercial officer at Nadex, noted prior to the election that equity indices such as the S&P 500 tend to “love a lower tax, lower regulation environment” which President Trump sought to provide during his four-year tenure. Yet the price of the S&P 500 has remained buoyant since the news of President-elect Biden's victory. Of course, the price of such equity indices also takes into account other market-moving factors such as the prospects of vaccinations and returning to a normal way of life in 2021.
Despite the positivity recently, there is a feeling among some that U.S. and European stocks could plateau in the coming weeks, given the tremendous amount of work remaining before anyone can claim the end of the pandemic.
Melinda Mills, director of the Leverhulme Centre for Demographic Science at the University of Oxford, said that it’s important to provide a clear distinction between the positive news on vaccine tests and the challenge of physically vaccinating the global population in the months ahead. “Vaccines and vaccination are two very different things,” warned Mills. She added that to achieve an “80% uptake” of vaccination to achieve “community protection”, governments need to get “serious” with public engagement strategies for 2021.
Even still, demand for well-established and emerging tech services and products looks set to decelerate in a reopening environment are lagging behind. "Work from home” tech stocks like Zoom Video Communications Inc. ZM are down 32% from its all-time high on October 19.
Aside from the obvious rise of vaccine stocks like Pfizer and AstraZeneca AZN, it’s the global hotel and airline stocks that have fared best since the Pfizer vaccine testing revelations. Major U.S. airlines like Delta Air Lines, Inc DAL and United Holdings, Inc UAL have soared, with the latter also in talks with the U.S. Treasury Department about extending its loan facility. Other reopening plays like Expedia Group Inc EXPE and Marriot International MAR have likewise rallied.
While a safe and effective vaccine could prove the ultimate game-changer for the global travel sector, efficient inoculation campaigns are still weeks if not months away, which may temper any further enthusiasm for these shares at least in the short term.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.